NCT00150410
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +2 more
- Locations
-
- Pfizer Investigational Site Mesa, Arizona, United States
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Tucson, Arizona, United States
- Pfizer Investigational Site Searcy, Arkansas, United States